1-3 of 3
Ralph R Weichselbaum, MD
Close
Sort by
Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD
Journal: Blood
Blood (2016) 128 (22): 4646.
https://doi.org/10.1182/blood.V128.22.4646.4646
Published: 2016
Journal Articles

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Nadim Mahmud, MD, PhD, David Peace, MD, John G. Quigley, MD, Santosh L. Saraf, MD, Enzo DeMasi, MD, Ralph R Weichselbaum, MD, Damiano Rondelli, MD
Journal: Blood
Blood (2013) 122 (21): 3285.
https://doi.org/10.1182/blood.V122.21.3285.3285
Published: 2013
Journal Articles

Anti-Leukemic Activity Is Increased with Low Dose Busulfan and Irradiation: A Preclinical Model

Pritesh R. Patel, MB, ChB, Dolores Mahmud, PhD, Wei Zhang, PhD, Tong Zhou, PhD, Nadim Mahmud, MD, PhD, Ralph R Weichselbaum, MD, Joe GN Garcia, MD, Damiano Rondelli, MD
Journal: Blood
Blood (2011) 118 (21): 4696.
https://doi.org/10.1182/blood.V118.21.4696.4696
Published: 2011